Patients with myelofibrosis (MF) have exceptionally poor quality of life and poor prognosis, with few options for treatment. There are several prognostic tools available to assess patient risk. This module explains the differences between these tools and how use the risk stratification tools that best matches the information available. A patient describes the burden of disease and the impact on their quality of life.